8 Matching Annotations
  1. Oct 2026
    1. The mGluR6 ligand-binding domain, but not the C-terminal domain, is required for synaptic localization in retinal ON-bipolar cells

      PMID: 34793838

      Gene: TRPM1

      HGNC: 7146

      Disease: congenital stationary night blindness 1C

      MONDO: MONDO:0013183

      InheritancePattern: autosomal recessive

      Prevalence: Congenital stationary night blindness has an estimated prevalence between 1 in 6,000 (PMID: 31427709) and 1 in 300,000 (PMID: 3487908). However, the prevalence of congenital stationary night blindness 1C specifically is unknown.

      Penetrance: Penetrance is thought to be complete.

    1. Presentation of TRPM1-Associated Congenital Stationary Night Blindness in Children

      PMID: 29522070

      Gene: TRPM1

      HGNC: 7146

      Disease: congenital stationary night blindness 1C

      MONDO: MONDO:0013183

      InheritancePattern: autosomal recessive

      Prevalence: Congenital stationary night blindness has an estimated prevalence between 1 in 6,000 (PMID: 31427709) and 1 in 300,000 (PMID: 3487908). However, the prevalence of congenital stationary night blindness 1C specifically is unknown.

      Penetrance: Penetrance is thought to be complete.

    1. Evidence for a Retroviral Insertion in TRPM1 as the Cause of Congenital Stationary Night Blindness and Leopard Complex Spotting in the Horse

      PMID: 24167615

      Gene: TRPM1

      HGNC: 7146

      Disease: congenital stationary night blindness 1C

      MONDO: MONDO:0013183

      InheritancePattern: autosomal recessive

      Prevalence: Congenital stationary night blindness has an estimated prevalence between 1 in 6,000 (PMID: 31427709) and 1 in 300,000 (PMID: 3487908). However, the prevalence of congenital stationary night blindness 1C specifically is unknown.

      Penetrance: Penetrance is thought to be complete.

    2. Previous gene expression analyses [17] did not detect expression of TRPM1 in the skin and retina of LP/LP CSNB individuals, suggesting that transcription of this gene was disrupted. However, when comparing raw read counts, we identified novel expression within intron 1, having 85 reads in the skin and 460 reads in the retina of the LP/LP horse compared to 0 and 4 reads (in the skin and retina respectively) of the lp/lp horse (Figure 3). De novo assembly of this transcript followed by PCR and genomic DNA sequencing identified a 1378 bp insertion in intron 1 (ECA1g. 108,297,929_108,297,930 ins1378) of TRPM1. In order to characterize this insertion we performed a blast analysis using RepeatMasker [27] (Figure S2). This insertion is a long terminal repeat (LTR) of an endogenous retrovirus (ERV) class II retro-element and is characterized by flanking regions of micro-homology, indicative of non-homologous end joining double stranded break repair as the mechanism of insertion (Figure 4A and Figure S2). Detection of this insertion by allele specific PCR confirmed complete association with the LP genotype (as predicted by phenotype) in tests of 511 horses (χ2=1022.00, p<<0.0005) and CSNB status in tests of 43 horses (χ2=43, p<<0.0005) (Table 2).

      ExperimentName: Horse model of TRPM1 loss-of-function

      NonHumanModel: Equus ferus caballus

      GeneAlteration: The horse has homozygous disruption of the TRPM1 gene by a naturally occurring insertion of a 1378 bp transposon in intron 1 (g. 108,297,929_108,297,930 ins1378). A previous publication by the same group has shown that TRPM1 expression is absent from the skin and retina of these horses (PMID: 18660533).

      ModelPhenotype: HP:0001053 (Hypopigmented skin patches), HP:0000591 (Abnormal sclera morphology), HP:0000662 (Nyctalopia), HP:0007984 (Electronegative electroretinogram),

      HumanPhenotype: HP:0000662 (Nyctalopia), HP:0000545 (Myopia), HP:0000572 (Visual loss), HP:0007984 (Electronegative electroretinogram), HP:0000958 (Dry skin), HP:0000964 (Eczema)

      ModelEvidence: The affected horses exhibit night blindness and abnormal dark-adapted ERG with absent b-wave and increased amplitude of a-wave (Figure 1). Both phenotypes are similar to the affected human patients. Melanocyte dysfunction is also shown by unpigmented areas of the skin (Figures 1 and 2) and the sclera of the eye (Figure 2A). These pigment phenotypes do not have a human equivalent, although some affected patients have been reported to have dry skin or a history of eczema (PMID: 19878917).

      ModelVariant: The model harbors a naturally occurring variant that does not have an equivalent / orthologous variant reported in human patients.

    1. The electroretinogram (ERG) of TRPM1-deficient (TRPM1−/−) mice had a normal a-wave, but no b-wave, indicating a loss of bipolar cell response. Finally, whole-cell patch-clamp recording from ON-bipolar cells in mouse retinal slices demonstrated that genetic deletion of TRPM1 abolished chemically simulated light responses from rod bipolar cells and dramatically altered the responses of cone ON-bipolar cells.

      ExperimentName: Mouse model of Trpm1 loss-of-function

      NonHumanModel: Mus musculus

      GeneAlteration: The mouse has homozygous disruption of the Trpm1 gene by targeted deletion of regions from exons 3, 4, and 5 (PMID: 19439586).

      ModelPhenotype: HP:0007984 (Electronegative electroretinogram)

      HumanPhenotype: HP:0000662 (Nyctalopia), HP:0000545 (Myopia), HP:0000572 (Visual loss), HP:0007984 (Electronegative electroretinogram)

      ModelEvidence: The affected mice exhibit abnormal dark-adapted ERG with absent b-wave and normal a-wave (Figure 3), similar to the affected human patients. Retinal slices from these mice exhibit defects in chemically stimulated light responses (Figure 4), indicating that Trpm1 is required for generating the depolarizing light response in ON-bipolar cells.

      ModelVariant: The model harbors a targeted deletion that does not have an equivalent / orthologous variant reported in human patients.

    2. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells

      PMID: 19861548

      Gene: TRPM1

      HGNC: 7146

      Disease: congenital stationary night blindness 1C

      MONDO: MONDO:0013183

      InheritancePattern: autosomal recessive

      Prevalence: Congenital stationary night blindness has an estimated prevalence between 1 in 6,000 (PMID: 31427709) and 1 in 300,000 (PMID: 3487908). However, the prevalence of congenital stationary night blindness 1C specifically is unknown.

      Penetrance: Penetrance is thought to be complete.

    1. MLSN Is a Plasma Membrane Protein Mediating Ca2+ Entry. To obtain additional evidence that members of the TRPM subfamily promote cation influx, we expressed the founding member of the TRPM subfamily, MLSN, in HEK293 cells and performed Ca2+ imaging. Expression of MLSN in these cells led to a pronounced Ca2+ entry upon switching the cells from the Ca2+-free to the Ca2+-containing solution; however, alterations in osmolarity had no effect (Fig. ​(Fig.44A, n = 280). Nontransfected cells or cells cotransfected with pYFP and the empty pcDNA3 vector did not display changes in Ca2+ concentration upon switching from the Ca2+-free to the Ca2+-containing bath solutions (Fig. ​(Fig.33D). As was the case with TRPM4, Ca2+ entry mediated by MLSN was blocked by La3+. There was no Sr2+ permeation, and Ba2+ entry was considerably slower than Ca2+ entry (Fig. ​(Fig.44B, n = 32), indicating that MLSN channels have a divalent cation selectivity with Ca2+ > Ba2+ ≫ Sr2+. To determine the subcellular localization of MLSN, we performed immunofluorescent microscopy on transfected HEK293 cells. The confocal images indicated that the MLSN protein was localized at or in close proximity to the plasma membrane (Fig. ​(Fig.44 C and D).

      Selection B- Gene function is consistent with phenotype.

      Title: TRPM1 (MLSN) is a plasma membrane protein that mediates the cellular influx of calcium and other divalent cations, leading to depolarization, as part of the depolarizing photoresponse within ON-bipolar cells of the retina.

      GOterm: GO:0005261 (cation channel activity), GO:0005262 (calcium channel activity)

      FunctionalEvidence: Exogenous expression of TRPM1 (MLSN) in HEK293 cells conferred the ability to allow entry of calcium, barium, and strontium ions, unlike the pYFP or empty vector controls (Figures 4A, 4B, 3C). Confocal microscopy also showed localization to the plasma membrane (Figures 4C, 4D).

      FunctionalHPO: HP:0000662 (Nyctalopia), HP:0000545 (Myopia), HP:0000572 (Visual loss), HP:0007984 (Electronegative electroretinogram)

      PhenotypeEvidence: This evidence is consistent with the view of congenital stationary night blindness 1C as a channelopathy caused by a defect in divalent cation influx, signal transduction, and the polarization / depolarization of ON-bipolar cells.

    2. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform

      PMID: 11535825

      Gene: TRPM1

      HGNC: 7146

      Disease: congenital stationary night blindness 1C

      MONDO: MONDO:0013183

      InheritancePattern: autosomal recessive

      Prevalence: Congenital stationary night blindness has an estimated prevalence between 1 in 6,000 (PMID: 31427709) and 1 in 300,000 (PMID: 3487908). However, the prevalence of congenital stationary night blindness 1C specifically is unknown.

      Penetrance: Penetrance is thought to be complete.